Path: biliary tract diseases Flashcards
1
Q
Types of biliary tract diseases
A
- Extrahepatic (CBD) bile duct obstruction: most common
- Primary biliary cirrhosis (PBC)
- Primary sclerosing cholangitis (PSC)
- Gallbladder: cholelithiasis, acute and chronic cholecystitis
2
Q
Extrahepatic bile duct obstruction etiologies
A
- Acute: choledocholithiasis, acute pancreatitis, acute stricture of CBD, masses (CCA, pancreatic CA)
- Chronic: long term strictures (chronic pancreatitis), extra hepatic biliary atresia (neonates), parasitic infections
3
Q
Presentation and path of extra hepatic bile duct obstruction 1
A
- Ab pain (often RUQ/epi)
- Fever and leukocytosis (cholangitis), Jaundice
- AST/ALT 100-200 (<300), markedly elevated AP
- Path: bile duct dilation (should be no space w/in duct) and periductal edema (if acute)
- If acute cholangitis (bacterial superinfection on CBD obstruction): PMNs w/in the lumen of the duct and invading the the basement membrane, along w/ preductal PMNs
- Possible to see micro abscesses around portal tracts, cholestasis
4
Q
Presentation and path of extra hepatic bile duct obstruction 2
A
- Bile duct infarcts (feathery degeneration) and bile lakes are rare (seen in later stages), but are diagnostic for extra hepatic bile duct obstruction
- Eventually there can be bile duct proliferation, mallory bodies in periportal hepatocytes (during chronic)
- There may be fibrosis around portal tracts if chronic obstruction, along w/ a mixed (lymphocyte and PMN) inflammation
- Periductal fibrosis occurs over months, w/ secondary biliary cirrhosis (all cirrhosis looks the same) occurring over years in adults (6 mo for children)
5
Q
Rx of extra hepatic bile duct obstruction
A
- ERCP for obstruction in CBD (i.e. stone, stricture), removal of tumor
- Antibios for the causative organisms (E Coli, klebsiella)
6
Q
PBC 1
A
- Chronic, slowly progressive cholestatic liver disease characterized by non-suppurative (mono inflammation) destruction of bile ducts w/ progression to biliary cirrhosis (and portal HTN)
- Occurs in middle aged women (30-70)
- There is insidious onset of pruritus, darkening of skin and eventually jaundice
- Malabsorption eventually occurs due to lack of bile (ADEK def)
- ERCP is nl in PBC b/c there is only inflammation of small intrahepatic bile ducts, large bile ducts not affected
7
Q
PBC 2
A
- Can also present w/ hepatomegaly, splenomegaly, or ASx
- Labs: AP generally >3x nl, AST/ALT slightly elevated, bili starts nl but becomes greatly elevated if disease progresses
- There is selective IgM elevation (high total protein, nl albumin), hypercholesterolemia, INR nl
- AutoAb: antimito Ab (AMA M2) almost always positive and is diagnostic
- Strong association w/ other autoimmune d/os e.g. Sjogren syndrome (dry mouth dry eyes, autoimmune)
8
Q
PBC pathology
A
- T cells target duct epithelium, unclear how AMA plays a role
- Early on there is infiltration of lymphocytes thru BM and in btwn epithelial cells (non-suppurative destruction)
- Biliary fibrosis occurs w/ cholangiocyte proliferation and mild portal fibrosis, granulomas may be seen
- Can lead to piecemeal necrosis: periportal inflammation and destruction of periportal hepatocytes (looks similar to autoimmune/viral hepatitis)
- As fibrosis continues there is portal-portal bridging fibrosis w/ decreased bile ducts
- Biliary cirrhosis develops, may see mallory bodies
- PBC cirrhosis can transform into HCC
9
Q
Rx of PBC
A
- Immunosuppression: steroids, AZP/6MP
- Cholestyramine to Rx pruritus (prevents reabsorption of bile)
- Urosdeoxycholic acid (UDCA): can help dissolve gallstones/thin bile
- Only cure is Tx
10
Q
PSC 1
A
- Chronic cholestatic liver disease characterized by diffuse fibrosis obliterative cholangitis and inflammation of both intra and extra hepatic bile ducts
- Predominantly in young-middle age males (around 40)
- Variable course but usually progressive to biliary cirrhosis and portal HTN
11
Q
PSC 2
A
- Usually associated w/ UC, common to have p-ANCA + (p-ANCA + seen in UC)
- Some are Asx, but common Sxs include pruritus, jaundice, hepatomegaly, splenomegaly, recurrent bouts of colangitis, eventually to cirrhosis in many pts
- The predicate fibrosis seen can lead to multiple strictures along the biliary tree
12
Q
PSC associated diseases
A
- Strongest association (75%) w/ UC
- Other autoimmune d/os: sjogren’s, AIH, RA, vasculitis
- Pathophys: genetic predisposition, possible acute insult to biliary tree (viral/bacterial infection, toxins, ischemia) and may alter bile ducts, marking them as foreign
- Followed by T cell attack
13
Q
Lab data for PSC
A
- AP greatly elevated (>3x nl)
- Slightly abnormal AST/ALT
- Elevated bili
- Positive p-ANCA in 75%
- AMA NEGATIVE
- Must do radiographic procedure (ERCP, MRCP) to identify strictures/dilations (beading of bile ducts)
14
Q
PSC path
A
- Both large and small ducts show periductal fibrosis w/ surrounding lymphocytic infiltrates (onion skinning)
- There can be variable stages of duct proliferation
- Eventually the lumens become obliterated from the huge amounts of fibrosis
- Progression w/ disease generally correlates to decreased number of ducts, w/ cirrhosis often showing no ducts at all
- Possible to see mallory bodies
- Cirrhosis occurs usually 3-5 yrs
- CCA is a possible complication of PSC
15
Q
Rx of PSC
A
- Cholestyramine for pruritus
- UDCA for gallstone dissolution
- Immunosuppression
- ERCP for stenting
- Tx